Cargando…
Anti-PD-1 and Novel Combinations in the Treatment of Melanoma—An Update
Until recently, distant metastatic melanoma was considered refractory to systemic therapy. A better understanding of the interactions between tumors and the immune system and the mechanisms of regulation of T-cells led to the development of immune checkpoint inhibitors. This review summarizes the cu...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019511/ https://www.ncbi.nlm.nih.gov/pubmed/31947592 http://dx.doi.org/10.3390/jcm9010223 |